Sales rise 33.33% to Rs 0.08 crore
Net profit of Rubra Medicaments reported to Rs 0.01 crore in the quarter ended September 2016. There were no net profit/loss reported during the previous quarter ended September 2015. Sales rose 33.33% to Rs 0.08 crore in the quarter ended September 2016 as against Rs 0.06 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales0.080.06 33 OPM %12.500 -PBDT0.010 0 PBT0.010 0 NP0.010 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content